No results for ‘’
Centenial Surgical Suture Ltd
NSE: BSE: 531380
₹97.05
(0%)
Wed, 16 Sept 2026, 11:40 pm
Market Cap (in Cr)35.41
PE Ratio0
Dividend0
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
- FAQs
Centenial Surgical Suture Analysis
dividend
Pros
Cons
- Unable to evaluate Centenial Surgical Suture's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Centenial Surgical Suture's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
Pros
- Centenial Surgical Suture is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Centenial Surgical Suture is profitable, therefore cash runway is not a concern.
- Centenial Surgical Suture is profitable, therefore cash runway is not a concern.
- Centenial Surgical Suture has no debt, it does not need to be covered by operating cash flow.
- Centenial Surgical Suture has no debt, it does not need to be covered by short term assets.
- Centenial Surgical Suture's cash and other short term assets cover its long term commitments.
- Centenial Surgical Suture has no debt compared to 5 years ago when it was 72.1%.
- Centenial Surgical Suture has no debt, therefore coverage of interest payments is not a concern.
- Centenial Surgical Suture has no debt.
Cons
- High level of physical assets or inventory.
management
Pros
- The tenure for the Centenial Surgical Suture board of directors is about average.
- Vijay's compensation has been consistent with company performance over the past year, both up more than 20%.
- The average tenure for the Centenial Surgical Suture management team is over 5 years, this suggests they are a seasoned and experienced team.
Cons
- Vijay's remuneration is higher than average for companies of similar size in India.
misc
Pros
Cons
- Centenial Surgical Suture is not covered by any analysts.
- Centenial Surgical Suture has significant price volatility in the past 3 months.
- BSE:531380 has not traded for 33 days.
past
Pros
- Centenial Surgical Suture's 1-year earnings growth exceeds its 5-year average (23% vs 4.5%)
- Centenial Surgical Suture's year on year earnings growth rate has been positive over the past 5 years.
- Centenial Surgical Suture's earnings growth has exceeded the IN Medical Equipment industry average in the past year (23% vs 21.7%).
Cons
- Centenial Surgical Suture used its assets less efficiently than the IN Medical Equipment industry average last year based on Return on Assets.
- Centenial Surgical Suture's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Centenial Surgical Suture has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
Pros
- Centenial Surgical Suture is good value based on assets compared to the IN Medical Equipment industry average.
- Centenial Surgical Suture is good value based on earnings compared to the IN Medical Equipment industry average.
- Centenial Surgical Suture is good value based on earnings compared to the India market.
Cons
- Centenial Surgical Suture's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Centenial Surgical Suture's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- 531380 underperformed the Medical Equipment industry which returned 60.7% over the past year.
- 531380 underperformed the Market in India which returned -14.5% over the past year.
- BSE:531380 is flat (0%) underperforming the Medical Equipment industry which returned 9.6% over the past month.
- BSE:531380 is flat (0%) underperforming the market in India which returned 8% over the past month.